Add to ORKGThe aim of this research is to determine whether amikacin dosage guidelines for multi - drug resistant mycobacterial infections achieve peaks of 35 - 45 mg/L (OD) or 65 - 80 mg/L (TW) and troughs <5 mg/L
Data on the optimal amikacin regimen during continuous renal replacement therapy (CRRT) are scarce a...
Background: Patients with clinical infections caused by the Mycobacterium avium complex (MAC) are tr...
Contains fulltext : 154302.pdf (Publisher’s version ) (Closed access)OBJECTIVES: T...
Background. Amikacin has been used for over 40 years in multidrug resistant tuberculosis (MDR-TB), b...
Background. Amikacin has been used for over 40 years in multidrug resistant tuberculosis (MDR-TB), b...
Objectives To identify the amikacin dosage regimens and drug concentrations consistent with good out...
International audienceBackground: Aminoglycosides have a concentration-dependent therapeutic effect ...
Background: Patients with clinical infections caused by the Mycobacterium avium complex (MAC) are tr...
Background: Amikacin is one of the antibiotics of choice for sepsis and septic shock. Pharmacokineti...
International audienceAmikacin antimicrobial effect has been correlated with the ratio of the peak c...
Objectives: To evaluate the importance of researh on aminoglicozids for rational pharmacotherapy. To...
Amikacin is a bactericidal aminoglycoside. Aminoglycosides inhibit bacterial protein synthesis. The ...
Data on the optimal amikacin regimen during continuous renal replacement therapy (CRRT) are scarce a...
New guidelines for the administration of amikacin are presented for neonates, children and adults, w...
Amikacin (BB-K8) is a new aminoglycoside antibiotic with an antimicrobial spectrum like that of gent...
Data on the optimal amikacin regimen during continuous renal replacement therapy (CRRT) are scarce a...
Background: Patients with clinical infections caused by the Mycobacterium avium complex (MAC) are tr...
Contains fulltext : 154302.pdf (Publisher’s version ) (Closed access)OBJECTIVES: T...
Background. Amikacin has been used for over 40 years in multidrug resistant tuberculosis (MDR-TB), b...
Background. Amikacin has been used for over 40 years in multidrug resistant tuberculosis (MDR-TB), b...
Objectives To identify the amikacin dosage regimens and drug concentrations consistent with good out...
International audienceBackground: Aminoglycosides have a concentration-dependent therapeutic effect ...
Background: Patients with clinical infections caused by the Mycobacterium avium complex (MAC) are tr...
Background: Amikacin is one of the antibiotics of choice for sepsis and septic shock. Pharmacokineti...
International audienceAmikacin antimicrobial effect has been correlated with the ratio of the peak c...
Objectives: To evaluate the importance of researh on aminoglicozids for rational pharmacotherapy. To...
Amikacin is a bactericidal aminoglycoside. Aminoglycosides inhibit bacterial protein synthesis. The ...
Data on the optimal amikacin regimen during continuous renal replacement therapy (CRRT) are scarce a...
New guidelines for the administration of amikacin are presented for neonates, children and adults, w...
Amikacin (BB-K8) is a new aminoglycoside antibiotic with an antimicrobial spectrum like that of gent...
Data on the optimal amikacin regimen during continuous renal replacement therapy (CRRT) are scarce a...
Background: Patients with clinical infections caused by the Mycobacterium avium complex (MAC) are tr...
Contains fulltext : 154302.pdf (Publisher’s version ) (Closed access)OBJECTIVES: T...